Table 1. Most significant miRNAs expressed in the saliva of CLP.

	Saliva
Target	LipCleft		Normal		ΔΔCT	2–(ΔΔCT)	Log2 (2–(ΔΔCT))
	Mean CT	Mean ΔCT	Mean CT	Mean ΔCT	Lipcleft	Lipcleft	Lipcleft
hsa-let-7e	28,03	5,24	27,77	3,41	1,83	0,28	–1,83
hsa-miR-16	20,21	–2,58	23,37	–0,99	–1,59	3,01	1,59
hsa-miR-24	18,83	–3,96	22,15	–2,21	–1,75	3,36	1,75
hsa-miR-28-3p	24,35	1,56	28,44	4,07	–2,51	5,70	2,51
hsa-miR-127	31,82	9,03	31,25	6,89	2,15	0,23	–2,15
hsa-miR-128a	28,35	5,56	31,70	7,34	–1,78	3,42	1,78
hsa-miR-132	24,15	1,36	27,82	3,45	–2,09	4,27	2,09
hsa-miR-135b	29,82	7,03	29,22	4,86	2,18	0,22	–2,18
hsa-miR-141	31,94	9,15	30,06	5,69	3,45	0,09	–3,45
hsa-miR-150	23,31	0,52	27,13	2,77	–2,25	4,76	2,25
hsa-miR-186	22,89	0,10	26,07	1,70	–1,60	3,03	1,60
hsa-miR-193a-5p	24,56	1,77	28,14	3,77	–2,01	4,02	2,01
hsa-miR-197	22,39	–0,40	26,14	1,78	–2,18	4,52	2,18
hsa-miR-223	13,55	–9,24	16,76	–7,61	–1,63	3,10	1,63
hsa-miR-324-3p	27,78	4,99	32,48	8,11	–3,12	8,70	3,12
hsa-miR-328	24,10	1,31	27,85	3,48	–2,17	4,50	2,17
hsa-miR-342-3p	23,54	0,75	27,18	2,81	–2,06	4,18	2,06
hsa-miR-345	23,79	1,00	27,63	3,26	–2,27	4,81	2,27
hsa-miR-361	27,58	4,79	31,20	6,84	–2,05	4,14	2,05
hsa-miR-484	19,77	–3,03	23,78	–0,58	–2,44	5,43	2,44
mmu-miR-491	26,57	3,77	29,90	5,53	–1,76	3,38	1,76
hsa-miR-502-3p	31,31	8,52	35,01	10,65	–2,12	4,36	2,12
hsa-miR-517c	35,43	12,64	34,67	10,31	2,33	0,20	–2,33
hsa-miR-532	25,22	2,43	28,53	4,16	–1,74	3,33	1,74
hsa-miR-652	26,44	3,65	30,26	5,90	–2,24	4,73	2,24
hsa-miR-660	25,01	2,21	28,21	3,85	–1,63	3,10	1,63
hsa-miR-744	26,91	4,12	30,29	5,92	–1,80	3,47	1,80
hsa-miR-212	29,15	6,36	33,43	9,07	–2,71	6,52	2,71
hsa-miR-511	32,48	9,68	31,88	7,52	2,17	0,22	–2,17

Differentially expressed miRNAs between patients affected by lip and palatal cleft and healthy individuals.